Tags

Type your tag names separated by a space and hit enter

Management of Osteomyelitis and Bone Loss in the Diabetic Charcot Foot and Ankle.
Clin Podiatr Med Surg. 2017 Jul; 34(3):381-387.CP

Abstract

Bone loss and destruction due to diabetic Charcot neuroarthropathy (CN) and osteomyelitis of the foot and ankle is a challenging clinical condition when lower extremity preservation is considered. Resection and excision of osteomyelitis and associated nonviable soft tissue can lead into large osseous and soft tissue defects that will most likely need the utilization of bone grafting and subsequent arthrodesis for stability and anatomic alignment. In the diabetic population with peripheral neuropathy, osseous instability can lead to subsequent lower extremity deformity, ulceration, infection and/or amputation. This article reviews the surgical approach in the presence of diabetic CN and concomitant osteomyelitis.

Authors+Show Affiliations

Mid-Atlantic Permanente Medical Group, Springfield Medical Center, 6501 Loisdale Court, Springfield, VA 22150, USA.Division of Podiatric Medicine and Surgery, Department of Orthopaedics, University of Texas Health Science Center San Antonio, 7703 Floyd Curl Drive, MSC 7776, San Antonio, TX 78229, USA. Electronic address: thomaszgonis@yahoo.com.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

28576196

Citation

Short, Daniel J., and Thomas Zgonis. "Management of Osteomyelitis and Bone Loss in the Diabetic Charcot Foot and Ankle." Clinics in Podiatric Medicine and Surgery, vol. 34, no. 3, 2017, pp. 381-387.
Short DJ, Zgonis T. Management of Osteomyelitis and Bone Loss in the Diabetic Charcot Foot and Ankle. Clin Podiatr Med Surg. 2017;34(3):381-387.
Short, D. J., & Zgonis, T. (2017). Management of Osteomyelitis and Bone Loss in the Diabetic Charcot Foot and Ankle. Clinics in Podiatric Medicine and Surgery, 34(3), 381-387. https://doi.org/10.1016/j.cpm.2017.02.008
Short DJ, Zgonis T. Management of Osteomyelitis and Bone Loss in the Diabetic Charcot Foot and Ankle. Clin Podiatr Med Surg. 2017;34(3):381-387. PubMed PMID: 28576196.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Management of Osteomyelitis and Bone Loss in the Diabetic Charcot Foot and Ankle. AU - Short,Daniel J, AU - Zgonis,Thomas, Y1 - 2017/03/22/ PY - 2017/6/4/entrez PY - 2017/6/4/pubmed PY - 2018/4/7/medline KW - Bone grafting KW - Bone loss KW - Charcot foot KW - Diabetes mellitus KW - External fixation KW - Osteomyelitis SP - 381 EP - 387 JF - Clinics in podiatric medicine and surgery JO - Clin Podiatr Med Surg VL - 34 IS - 3 N2 - Bone loss and destruction due to diabetic Charcot neuroarthropathy (CN) and osteomyelitis of the foot and ankle is a challenging clinical condition when lower extremity preservation is considered. Resection and excision of osteomyelitis and associated nonviable soft tissue can lead into large osseous and soft tissue defects that will most likely need the utilization of bone grafting and subsequent arthrodesis for stability and anatomic alignment. In the diabetic population with peripheral neuropathy, osseous instability can lead to subsequent lower extremity deformity, ulceration, infection and/or amputation. This article reviews the surgical approach in the presence of diabetic CN and concomitant osteomyelitis. SN - 1558-2302 UR - https://www.unboundmedicine.com/medline/citation/28576196/Management_of_Osteomyelitis_and_Bone_Loss_in_the_Diabetic_Charcot_Foot_and_Ankle_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0891-8422(17)30030-7 DB - PRIME DP - Unbound Medicine ER -